Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
MarketWatch

Emulate Applauds FDA's Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
C&EN

Emulate advances its organ emulation chip

Emulate and Laboratory Corp. of America’s Covance unit have formed a partnership to assess “organs on chips” technology for preclinical drug evaluation. Emulate will bring to the partnership its ...
C&EN

FDA’s shift from animal testing opens doors for organoid makers

The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...
Reuters

Seres, Emulate collaborate to advance Emulate's intestine-chip platform

* Seres and Emulate will work to advance Emulate's intestine-chip platform, a living-tissue-based system that models human intestine ...